For the latest coronavirus care instructions and resources, please call our COVID-19 hotline at 208-381-9500. Find additional information and resources here and learn more about how we're working to keep you healthy and safe.

toggle mobile menu Menu
toggle search menu

Site Navigation



Classes and Events

Evidence-Based Aphasia Treatment: Principles and Procedures

This conference has been canceled due to coronavirus (COVID-19) concerns. Please email us with any questions or concerns.
  • Venue & Location

    location icon
    (South Tower, Anderson Center)
    (5th Floor)
    101 W. Bannock St. (Parking Garage)
    Boise, ID 83702
  • Fee & Registration

    price tag icon
    Varies, No Registration Required


Presented by Leora R. Cherney, PhD, BC-ANCDS, CCC-SLP

In recent years, there has been a proliferation of research targeting various aspects of aphasia treatment. These range from studies addressing the development, theoretical underpinnings and efficacy of specific treatments to more general issues such as intensity and dose that impact learning and outcomes, regardless of the treatment being administered.

This workshop describes the procedures for administering several of the newest aphasia treatment techniques, emphasizing their theoretical background and current evidence supporting their efficacy. Treatments that target impairment and activity-participation levels will be included. Practical issues such as dosage and service delivery models that improve access to and outcomes from treatment will be discussed.


At the end of this course, participants will be able to:

  • Describe components related to “dose” of aphasia therapy.
  • List procedures for administering at least four evidence-based aphasia treatments.
  • Differentiate impairment and activity/participation level treatments.
  • Explain the importance of considering social/life participation approaches in the treatment of aphasia.


  • 8:30-9 a.m.: Neuroplasticity and Dose Considerations
  • 9-10:15 a.m.: Intensive Language Action Therapy
  • 10:15-10:30 a.m.: Break
  • 10:30 a.m.-12 p.m.: Addressing the Impairment: Semantics
  • 12-1 p.m.: Lunch
  • 1-2 p.m.: Addressing the Impairment: Phonology
  • 2-3 p.m.: Addressing the Impairment: Syntax
  • 3-3:15 p.m: Break
  • 3:15-4:15 p.m.: Addressing the Activity/Participation Level: Scripting and more
  • 4:15-5 p.m.: Service delivery models: Groups and ICAPs

ASHA Continuing Education Approved Provider

This course is offered for .7 ASHA CEUs.
Intermediate, professional level.


Registration Instructions

Registration is required. Email us for more information.


  • St. Luke's employees: $30
  • Early-bird students: $30
  • Early-bird general: $120
  • Students after April 1, 2020: $50
  • General after April 1, 2020: $150

Special Instructions

This class is conducted in St. Luke's South Tower Anderson Center (5th floor) which is directly east of (and attached to) the South Tower parking garage where free parking is available. 

The South Tower ground-level pedestrian entrance is just east of the cul-de-sac at the corner of W. Bannock Street and N. First Street.

Motorists should enter the South Tower parking garage at 101 W. Bannock Street and park on level 4 (top) in spaces designated for patients.

Enter the South Tower through entrance 4A, go through the double doors, and go to the 5th floor.

Leora R. Cherney, PhD, BC-ANCDS, CCC-SLP

Dr. Cherney is the scientific chair, Think and Speak Lab, at the Shirley Ryan AbilityLab (formerly the Rehabilitation Institute of Chicago) and professor of both physical medicine and rehabilitation and communication sciences and disorders at Northwestern University. She has more than 35 years of clinical experience working with adults with neurogenic communication disorders and is the founder and director of the AbilityLab’s Center for Aphasia Research and Treatment.

Dr. Cherney is board-certified in neurologic communication disorders by the Academy of Neurologic Communication Disorders and Sciences (ANCDS) and has received the honors of ANCDS, the American Speech-Language-Hearing Association and the Illinois Speech-Language Hearing Association. She has co-authored four books and has more over 90 publications in refereed journals, textbooks and other periodicals. She regularly presents at workshops and conferences nationally and internationally.

Dr. Cherney’s research interests, which have been continuously federally funded for more than 20 years, have focused on treatment approaches for aphasia and on attention and discourse problems in adults with cognitive-communication disorders.


  • Receives salary from the Shirley Ryan AbilityLab
  • Receives an honorarium from St. Luke’s Health System
  • Principal investigator on NIDILRR and NIH funded research grants
  • No non-financial relationships to disclose